Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

686819.pdf (2.43 MB)

Document type

Article

Version

Published version

Publication date

2018-06-15

Publication license

cc-by (c) Toledo Pons, Nuria et al., 2018
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/132830

Bone marrow characterization in COPD: a multi-level network analysis

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1186/s12931-018-0824-x

Abstract

BACKGROUND: Bone marrow (BM) produces hematopoietic and progenitor cells that contribute to distant organ inflammation and repair. Chronic obstructive pulmonary disease (COPD) is characterized by defective lung repair. Yet, BM composition has not been previously characterized in COPD patients. METHODS: In this prospective and controlled study, BM was obtained by sternum fine-needle aspiration in 35 COPD patients and 25 healthy controls (10 smokers and 15 never-smokers). BM cell count and immunophenotype were determined by microscopy and flow cytometry, respectively. Circulating inflammatory (C-reactive protein, IL-6, IL-8) and repair markers (HGF, IGF, TGF-β, VEGF) were quantified by ELISA. Results were integrated by multi-level network correlation analysis. RESULTS: We found that: (1) there were no major significant pair wise differences between COPD patients and controls in the BM structural characteristics; (2) multi-level network analysis including patients and controls identifies a relation between immunity, repair and lung function not previously described, that remains in the COPD network but is absent in controls; and (3) this novel network identifies eosinophils as a potential mediator relating immunity and repair, particularly in patients with emphysema. CONCLUSIONS: Overall, these results suggest that BM is activated in COPD with impaired repair capacity in patients with more emphysema and/or higher circulating eosinophils.

Subject

Malalties pulmonars obstructives cròniques, Medul·la òssia, Assaigs clínics

Subject (English)

Chronic obstructive pulmonary diseases, Bone marrow, Clinical trials

Citation

Collections

Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citation

TOLEDO PONS, Nuria, et al. Bone marrow characterization in COPD: a multi-level network analysis. Respiratory Research. 2018. Vol. 19, num. 1, pags. 118-127. ISSN 1465-993X. [consulted: 10 of August of 2026]. Available at: https://hdl.handle.net/2445/132830

Export metadata

JSON - METS

Share record